Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths

Share this content:
Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths
Fentanyl or Analogs Tied to More Than Half of All Opioid Deaths

TUESDAY, Oct. 31, 2017 (HealthDay News) -- Fentanyl was involved in more than half of opioid overdose deaths reported in the second half of 2016, according to a study published online Oct. 27 in Morbidity and Mortality Weekly Report.

Julie K. O'Donnell, Ph.D., from the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, and colleagues used data from 10 states participating in the CDC's Enhanced State Opioid Overdose Surveillance program to describe opioid overdose deaths from July through December 2016 that tested positive for fentanyl; fentanyl analogs; or U-47700, an illicit synthetic opioid.

The researchers found that fentanyl was detected in more than half (56.3 percent) of the 5,152 opioid overdose deaths in the 10 states. More than half of fentanyl-involved deaths (57 percent) also tested positive for other illicit drugs, such as heroin. Carfentanil, furanylfentanyl, and acetylfentanyl were the fentanyl analogs identified most frequently, and fentanyl analogs were present in more than 10 percent of opioid overdose deaths in four states.

"Expanded surveillance for opioid overdoses, including testing for fentanyl and fentanyl analogs, assists in tracking the rapidly changing illicit opioid market and informing innovative interventions designed to reduce opioid overdose deaths," conclude the authors.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »